COLL - Collegium Pharmaceutical Inc. (COLL) CEO Joe Ciaffoni on Q4 2019 Results - Earnings Call Transcript
Collegium Pharmaceutical, Inc. (COLL)
Q4 2019 Results Conference Call
February 27, 2020 05:00 PM ET
Company Participants
Alex Dasalla - Head of Investor Relations
Joe Ciaffoni - President and Chief Executive Officer
Paul Brannelly - Chief Financial Officer
Scott Dreyer - Chief Commercial Officer
Conference Call Participants
Zach Sachar - Piper Sandler
David Steinberg - Jefferies
Serge Belanger - Needham & Company
Tim Lugo - William Blair
Brandon Folkes - Cantor Fitzgerald
Presentation
Operator
Good day, ladies and gentlemen and thank you for standing by and welcome to the Fourth Quarter 2019 Collegium Pharmaceutical Earnings